Have any clinical trials evaluated the safety and efficacy of Memory Blast products?
Executive summary
Available sources do not mention any products called “Memory Blast” or clinical trials specifically evaluating a product by that name; none of the provided search results identify a Memory Blast clinical trial or company trial listing (available sources do not mention “Memory Blast”) [1] [2] [3]. The materials instead document many active Alzheimer’s and memory-related trials across universities, government portals, and drug pipelines — 182 AD trials assessing 138 drugs were catalogued on Jan 1, 2025 — but no direct reference to a “Memory Blast” program [3] [2] [4].
1. No mention of “Memory Blast” in major trial listings
Searchable trial repositories and institutional trial pages in the provided set — including UCSF Memory and Aging Center clinical-trials listings (which host numerous early‑phase and platform studies) and the NIA/Alzheimers.gov trial finders — show many active studies but do not list any trial named “Memory Blast” or trials sponsored by an entity of that name; therefore, available sources do not document a Memory Blast clinical trial [2] [5] [6] [4].
2. The Alzheimer pipeline is active — but not by that product name
Comprehensive reviews of the Alzheimer’s drug-development pipeline show a heavy, verifiable clinical-trial load — 182 trials assessing 138 drugs as of Jan 1, 2025, across Phases 1–3 — demonstrating substantial trial activity in memory/AD research. These data confirm many opportunities for new agents to enter human testing, but the pipeline summary and related clinical‑trial registries cited do not mention Memory Blast [3].
3. Institutional trial pages illustrate where a Memory Blast study would appear
If a company or product were running a legitimate human trial, it would typically appear on institutional trial pages or national registries: examples here include UCSF’s catalog of disease-specific Phase 1–3 studies and UC San Diego and Mass. ADRC “join a study” pages that list specific trials and interventions. The fact that those pages enumerate many named trials yet do not include Memory Blast supports the absence of evidence in this dataset [2] [7] [8].
4. News and press excerpts in the dataset focus on different compounds
Provided news snippets describe specific investigational drugs and programs — e.g., an experimental GL-II-73 moving toward a Phase 1 human trial in 1H 2025 and large company trials such as Novo Nordisk’s semaglutide Alzheimer programs — but none reference Memory Blast. That indicates the dataset’s topical coverage would likely have captured any prominent “Memory Blast” human trial if one existed and was publicly announced [1] [9].
5. Types of evidence you should expect for a bona fide clinical trial
Typical public evidence for a clinical trial includes a ClinicalTrials.gov registration, institutional trial pages (UCSF, UCSD, MADRC), press releases describing FDA IND or IDE clearances, and peer‑reviewed protocol/pipeline listings. The sources here show those signposts for other agents but do not show them for Memory Blast; therefore, available sources do not mention the regulatory or registry records one would expect [2] [10] [3].
6. Alternative explanations and limitations of this review
Absence of evidence in these specific sources is not proof that no Memory Blast trial exists elsewhere. It may be that Memory Blast is a consumer supplement, a brand marketed outside academic/regulatory channels, a very new program not yet registered publicly, or listed in databases not included among these search results. The current reporting set simply does not contain a trial registry entry, institutional listing, or peer-reviewed mention of Memory Blast (available sources do not mention “Memory Blast”) [3] [2].
7. What to do next if you need confirmation
Check ClinicalTrials.gov and equivalent national registries directly for any trial titled “Memory Blast,” search company press releases or FDA/EMA IND/IDE correspondence for that brand name, and inspect product labeling or retailer pages to determine whether it is marketed as a supplement (consumer product) rather than an investigational medicinal product. The sources provided here point to where legitimate clinical trials normally appear — clinical trial portals (Alzheimers.gov, NIA), academic center lists (UCSF, UCSD, MADRC) — and none show Memory Blast [4] [6] [2] [7] [8].
Sources cited in this report are limited to the provided documents, which document many Alzheimer’s and memory‑related trials but do not mention “Memory Blast” in any clinical‑trial context [3] [2] [1].